Multiple myeloma
Conditions
Interventions
The patients with multiple myeloma undergo Methionine PET/CT, and compare the result with current diagnostic criteria including FDG-PET/CT.In this process, histopathological findings, clinical finding
Sponsors
Nathional Center for Global Health and Medicine. Division of Nuclear Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) adult 2) Patient with pathologically diagnosed as multiple myeloma 3) Completed the written informed consent.
Exclusion criteria
Exclusion criteria: 1)Patient in emargency state 2)Uncontorolable diabetics 3)Patient with severe comorbid disease includng liver dysfunction, renel failure or metabolic damage. 4)Patient with psychiatric disease 5)pregnant female, possible pregnant female, breast-feeding woman 6) allergy for Methionine 7) Those who are determined as not appropriate for the study by the principle investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To explore how Methionin PET/CT can contribute to initial diagnosis, treatment plannning and therapeutic effect of multiple myeloma. | — |
Countries
Japan
Contacts
Public ContactRyogo Minamimoto
Nathional Center for Global Health and Medicine Division of Nuclear Medicine
Outcome results
None listed